InvestorsHub Logo
Followers 17
Posts 898
Boards Moderated 0
Alias Born 09/28/2014

Re: bas2020 post# 687107

Thursday, 04/25/2024 12:12:51 PM

Thursday, April 25, 2024 12:12:51 PM

Post# of 700356

“Certainly, we don't know what is meant by "franchise", but it could be as simple as licensing out the technology to others who can produce it for their designated markets, including use in combo therapies.”


Yes, of course, many opportunities present themselves with NWBO’s breakthrough technology but with the current silence, we can only speculate. The point I was attempting to highlight in my post was the “administered in community settings” verbiage wherein brick and mortar location is not always available.

Further, an interesting nugget, EW Healthcare Partners held Cognate BioServices in their portfolio overseen by Evis Hursever, Managing Director, prior to CRL buyout. Presently, Ms. Hursever, chairs the Board of Germfree,

Thank you for adding additional information; we only have each other to depend on as we offer our thoughts and due diligence despite all the neighborhood pests on the board.

Best
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News